Discover how Cooper-Standard Holdings improved operations in Q4 2024, leveraging innovations and cost efficiencies amid challenges.
We expect year-over-year growth of Nights and Experiences Booked in Q1 2025 to be relatively stable compared to Q1 2024.” ...
He confirmed Q4 adjusted revenue of $800M and adjusted EBITDA margin at 4%, both at the higher end of expectations. Skelton emphasized new business growth, with improved retention and quarter-over ...
Says 2025 will be a year of transition. Says 2025 guidance reflects that transition. Says 2025 expenses will be lower than 2024. Sees FY25 ...
Q4 2024 Management View CEO Ruud Joosten highlighted the company's strong performance in 2024, with nearly all activities performing well. Adjusted EBITDA reached €333 million, reflecting a 5.2% ...
Dairy heavyweight Saputo has “withdrawn” a key EBITDA target but suggested a new milk-pricing formula in the US would bring an additional profit benefit. “Market conditions have not ...
Nuvama expects 31 per cent and 20 per cent YoY growth in BPC and Fashion GMV respectively, with slight improvement in Ebitda margin. Shares of FSN E-Commerce Ventures dropped about a per cent to ...
EBITDA stands for Earnings before Interest ... it is one of the riskiest investment forms possible. Currency trading on margin involves high risk, and is not suitable for all investors.
On the operational front, the company posted Rs 141 crore in EBiTDA or earnings before interest, taxes, depreciation and amortisation, while it was Rs 99 crore in the year-ago period, marking a 42 per ...
EBITDA improved by 38.7% to Rs 579.97 crore in Q3 FY25 from Rs 418.29 crore in Q3 FY24. EBITDA margin remained unchanged at 15.7%. Profit before tax in Q3 FY25 stood at Rs 254.14 crore, up by 35.2% ...
The EBITDA margin expanded significantly to 38.4% versus 30.1% in Q3FY24. Suven Pharmaceuticals reported strong growth in the third quarter of FY25, driven primarily by its pharma CDMO segment, which ...
The company reported a 78.5% surge in EBITDA to ₹158.1 crore in Q3FY25, against ₹88.6 crore a year ago. The EBITDA margin expanded to 30.8% from 20.2% in the previous year, driven by the ongoing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results